Targeting immune dysregulation in chronic spontaneous urticaria: beyond antihistamines
Young-Min Ye
Korean J Intern Med. 2026;41(3):418-431.   Published online 2026 May 1     DOI: https://doi.org/10.3904/kjim.2025.374
Citations to this article as recorded by Crossref logo
Lysophosphatidic Acid Receptor 5 (LPA5) Antagonist AS2717638 Attenuates Allergic Asthma by Reducing Mast Cell Degranulation and Th2 Inflammation in Mice
Seung-Won Jeong, Dong-Soon Im
International Journal of Molecular Sciences.2026; 27(16): 7296.     CrossRef
Beyond Omalizumab: Emerging Biologic and Small Molecule Therapies in Chronic Spontaneous Urticaria
Sahibpreet Kaur, Muthu Sendhil Kumaran, Saumya Singh, Davinder Parsad
Clinical & Experimental Allergy.2026; 56(11): 1373.     CrossRef
Shared mediators, divergent networks: a tissue-response hypothesis for discordant phenotypes in chronic spontaneous urticaria and atopic dermatitis
Young-Min Ye, Michihiro Hide
Frontiers in Allergy.2026;[Epub]     CrossRef
Comorbidities in Chronic Spontaneous Urticaria: Integrating Disease Drivers and Systemic Consequences
Joo-Hee Kim, Mi-Ae Kim, Young-Min Ye
International Journal of Molecular Sciences.2026; 27(21): 9615.     CrossRef